[go: up one dir, main page]

WO1994013789A3 - Oligonucleotides presentant une activite de clivage de l'arn - Google Patents

Oligonucleotides presentant une activite de clivage de l'arn Download PDF

Info

Publication number
WO1994013789A3
WO1994013789A3 PCT/GB1993/002486 GB9302486W WO9413789A3 WO 1994013789 A3 WO1994013789 A3 WO 1994013789A3 GB 9302486 W GB9302486 W GB 9302486W WO 9413789 A3 WO9413789 A3 WO 9413789A3
Authority
WO
WIPO (PCT)
Prior art keywords
oligonucleotides
cleavage activity
rna cleavage
increased stability
stability against
Prior art date
Application number
PCT/GB1993/002486
Other languages
English (en)
Other versions
WO1994013789A2 (fr
Inventor
Janos Ludwig
Fritz Benseler
Gerd Kotzorek
Original Assignee
Ribonetics Gmbh
Janos Ludwig
Fritz Benseler
Gerd Kotzorek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribonetics Gmbh, Janos Ludwig, Fritz Benseler, Gerd Kotzorek filed Critical Ribonetics Gmbh
Priority to EP94905771A priority Critical patent/EP0672122A1/fr
Priority to AU59741/94A priority patent/AU5974194A/en
Publication of WO1994013789A2 publication Critical patent/WO1994013789A2/fr
Publication of WO1994013789A3 publication Critical patent/WO1994013789A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/318—Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
    • C12N2310/3183—Diol linkers, e.g. glycols or propanediols
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des oligonucléotides présentant une activité de clivage de l'ARN représentés par la séquence (I) dans laquelle, ----X et Y---- sont des séquences de reconnaissance de l'ARN spécifique à une cible, A, C, G et U sont des désoxynucléotides et au moins un a et/ou g représente respectivement un dérivé de guanosine ou d'adénosine à substitution 2', P correspond à a) A-U ou b) C-G et, W représente soit i) une séquence nucléotidique à boucle, ou ii) des ponts de diol connectés à des liaisons de dérivés de phosphodiester ou de phosphotriester neutre substitué. Lesdits oligonucléotides peuvent présenter une stabilité accrue contre la dégradation par RNase, une stabilité accrue contre la dégradation par exonucléase, ainsi qu'une plus grande facilité de fixation cellulaire.
PCT/GB1993/002486 1992-12-04 1993-12-03 Oligonucleotides presentant une activite de clivage de l'arn WO1994013789A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP94905771A EP0672122A1 (fr) 1992-12-04 1993-12-03 Oligonucleotides presentant une activite de clivage de l'arn
AU59741/94A AU5974194A (en) 1992-12-04 1993-12-03 Oligonucleotides with rna cleavage activity

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929225427A GB9225427D0 (en) 1992-12-04 1992-12-04 Oligonucleotides with rna cleavage activity
GB9225427.5 1992-12-04

Publications (2)

Publication Number Publication Date
WO1994013789A2 WO1994013789A2 (fr) 1994-06-23
WO1994013789A3 true WO1994013789A3 (fr) 1994-08-04

Family

ID=10726157

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1993/002486 WO1994013789A2 (fr) 1992-12-04 1993-12-03 Oligonucleotides presentant une activite de clivage de l'arn

Country Status (4)

Country Link
EP (1) EP0672122A1 (fr)
AU (1) AU5974194A (fr)
GB (1) GB9225427D0 (fr)
WO (1) WO1994013789A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09502092A (ja) * 1993-09-02 1997-03-04 リボザイム・ファーマシューティカルズ・インコーポレイテッド 非ヌクレオチドを含有する酵素性核酸
AU730934B2 (en) * 1993-09-02 2001-03-22 Ribozyme Pharmaceuticals, Inc. Non-nucleotide containing enzymatic nucleic acid
WO1995006764A2 (fr) * 1993-09-03 1995-03-09 Vpi Holdings Ltd. Oligonucleotides ayant une activite de segmentation de l'arn
JPH10501809A (ja) * 1994-06-22 1998-02-17 ネクスター ファーマスーティカルズ，インコーポレイテッド 分子内求核置換による公知および新規２′−ヌクレオシドの新規製造方法
WO1997018312A1 (fr) * 1995-11-14 1997-05-22 Vimrx Holdings, Ltd. Oligomeres chimeriques possedant une activite de clivage de l'arn
US6610478B1 (en) 1996-08-16 2003-08-26 Yale University Phenotypic conversion of cells mediated by external guide sequences
EP2256133B1 (fr) 1997-01-08 2016-12-14 Sigma-Aldrich Co. LLC Bio-conjugaison de macromolécules
US7427678B2 (en) 1998-01-08 2008-09-23 Sigma-Aldrich Co. Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
US7098326B2 (en) 2002-01-23 2006-08-29 Sigma-Aldrich Co. Methods for the integrated synthesis and purification of oligonucleotides
KR20050006221A (ko) * 2002-05-06 2005-01-15 제네랩스 테크놀로지스, 인코포레이티드 Ｃ형 간염 바이러스 감염 치료용의 뉴클레오시드 유도체
US7615629B2 (en) 2002-12-31 2009-11-10 Sigma-Aldrich Co. Methods and compositions for the tandem synthesis of two or more oligonucleotides on the same solid support

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991019789A1 (fr) * 1990-06-19 1991-12-26 Commonwealth Scientific And Industrial Research Organisation Endonucleases
WO1992007065A1 (fr) * 1990-10-12 1992-04-30 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Ribozymes modifies

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991019789A1 (fr) * 1990-06-19 1991-12-26 Commonwealth Scientific And Industrial Research Organisation Endonucleases
WO1992007065A1 (fr) * 1990-10-12 1992-04-30 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Ribozymes modifies

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BENSELER, F. ET AL: "Hammerhead-like molecules containing non-nucleoside linkers are active RNA catalysts", J. AM. CHEM. SOC., 115 (18),, 8 September 1993 (1993-09-08), pages 8483 - 8484 *
FU, D.-J. & MCLAUGHLIN, L.: "Importance of specific purine amino and hydroxyl groups for efficient cleavage by a hammerhead ribozyme", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 89, no. 9, 1 May 1992 (1992-05-01), WASHINGTON US, pages 3985 - 3989 *
MARRIOTT, J. ET AL.: "synthesis of 2'-thioadenosine", CARBOHYDRATE RESEARCH, vol. 216, 22 September 1991 (1991-09-22), AMSTERDAM NL, pages 257 - 269 *
RANGANATHAN, R. & LARWOOD, D.: "Facile conversion of adenosine into new 2'-substi-tuted-2'-deoxy-arabinofuranosyladenine derivatives: stereospecific synthesis of 2'-azido-2'-deoxy-, 2'-amino-2'-deoxy-, and 2'mercapto--2'-deoxy-beta-D-arabino- furanosyladenines", TETRAHEDRON LETTERS, vol. 45, 1978, OXFORD GB, pages 4341 - 4244 *

Also Published As

Publication number Publication date
EP0672122A1 (fr) 1995-09-20
GB9225427D0 (en) 1993-01-27
AU5974194A (en) 1994-07-04
WO1994013789A2 (fr) 1994-06-23

Similar Documents

Publication Publication Date Title
HU9501963D0 (en) 7-deazapurine modified oligonucleotides
WO1994013789A3 (fr) Oligonucleotides presentant une activite de clivage de l'arn
CA2266748A1 (fr) Oligonucleotides antisens chimeres a trois composants
ATE139255T1 (de) Oligonukleotidanaloga mit neuartigen bindungen
EP1044987A3 (fr) Oligonucléotides modifiés en 2' à ouverture
AU3906895A (en) DNA amplification fingerprinting
FR2714383B1 (fr) Contrôle de l'expression de gènes.
WO2004042029A3 (fr) Compositions oligomeres possedant des bases modifiees destinees a se lier a la cytosine, l'uracile ou la thymine et leur utilisation dans la modulation genique
HU912215D0 (en) Oligonucleotide analogues containing terminal 3',3'- or 5',5'-intermolecular bounds
CA2278715A1 (fr) Oligonucleotides modifies par aminooxy
DE69332665D1 (de) Methode um mrna zu klonieren
Capaldi et al. Use of the 1-(2-fluorophenyl)-4-methoxypiperidin-4-yl (Fpmp) and related protecting groups in oligoribonucleotide synthesis: stability of internucleotide linkages to aqueous acid
WO1993017651A3 (fr) Analogues nucleosidiques antiviraux, leur fabrication et leur utilisation
AU3862193A (en) Dna sequences, fragments and derivatives thereof
EP0677056A1 (fr) Alkylphosphonates et alkylphosphonothioates d'oligonucleotides.
CA2296769A1 (fr) Facteur modifie affectant le tissu dorsal et composition a base de ce facteur
WO1995000638A3 (fr) Oligonucleotides antisens et leur emploi therapeutique dans les infectiosn a vih
WO2000008141A3 (fr) Oligonucleotides courts destines a inhiber l'expression de vegf
IL108719A0 (en) Expression constructs containing hiv inhibitory antisense and other nucleotide sequences, retroviralvectors and recombinant retroviruses containing them
WO1994005791A3 (fr) Facteur influant sur la croissance du tissu dorsal et compositions
ATE87932T1 (de) Alpha-oligonukleotide.
WO2000008140A3 (fr) Oligonucleotides antisens destines a inhiber l'expression de vegf
AU6144294A (en) Plant virus resistance conferring polyribozyme and resistant plants producing same
EP0397463A3 (fr) Construction de séquences d'ADN synthétique bicaténaire
AU5337690A (en) Method for stabilizing the hybridization of complementary polynucleotide sequences

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page

Free format text: ABSTRACT REPLACED BY CORRECT ABSTRACT

WWE Wipo information: entry into national phase

Ref document number: 1994905771

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1994905771

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1994905771

Country of ref document: EP